Health Catalyst Is Maintained at Buy by Citigroup

Dow Jones03:14 · Ratings

Citi Maintains Health Catalyst(HCAT.US) With Buy Rating, Cuts Target Price to $10

Futu NewsJan 10 20:34 · Ratings

Express News | Health Catalyst Inc : Citigroup Cuts Target Price to $10 From $10.50

BreakingsJan 10 19:03

RBC Capital Maintains Health Catalyst(HCAT.US) With Hold Rating, Maintains Target Price $9

Futu NewsJan 10 10:31 · Ratings

RBC Capital Reaffirms Their Hold Rating on Health Catalyst (HCAT)

TipRanksJan 10 09:51 · Ratings

Health Catalyst Raised to Overweight From Sector Weight by Keybanc

Dow JonesJan 9 04:28 · Ratings